Vlad Coric - 31 Dec 2021 Form 5 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role: Chief Executive Officer, Director
Signature: /s/ George Clark, Attorney-in-Fact
Issuer symbol: BHVN
Transactions as of: 31 Dec 2021
Transactions value $: $0
Form type: 5
Filing time: 11 Feb 2022, 20:15:45 UTC
Previous filing: 26 Nov 2021
Next filing: 07 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Gift	$0	-29,783	-29.8%	$0.000000	70,217	21 Jun 2021	By The Vladimir Coric GRAT - 2019
transaction	BHVN	Common Shares	Gift	$0	+29,783	+116%	$0.000000	55,355	21 Jun 2021	Direct
transaction	BHVN	Common Shares	Gift	$0	-17,500	-3.72%	$0.000000	452,500	26 Nov 2021	By: The Vladimir Coric Family Trust	F1
transaction	BHVN	Common Shares	Gift	$0	-17,500	-5.29%	$0.000000	313,500	26 Nov 2021	By The Vladimir Coric Marital Trust	F1
holding	BHVN	Common Shares						19,130	31 Dec 2021	By 401(K) Plan

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in a trust for the benefit of the reporting person's family members, excluding the reporting person. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the reporting person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares are held in a trust for the benefit of the reporting person's family members, excluding the reporting person. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the reporting person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.